Rigaku ZSX Primus Application Note: Lubricating Oil Analysis by WDXRF According to AST... (The Woodlands TX (PRWEB) December 06 201...)

Rigaku ZSX Primus Application Note: Lubricating Oil Analysis by WDXRF According to ASTM D6443-04

Date:12/6/2012

The Woodlands, TX (PRWEB) December 06, 2012

Rigaku Corporation is pleased to announce the publication of a new application report on the Rigaku ZSX Primus sequential wavelength dispersive X-ray fluorescence (WDXRF) spectrometer. Application Note #5003 demonstrates quantitative analysis of lubricating oil in accordance with ASTM method D6443-04, "Standard Test Method for Determination of Calcium, Chlorine, Copper, Magnesium, Phosphorus, Sulfur, and Zinc in Unused Lubricating Oils and Additives by Wavelength Dispersive X-ray Fluorescence Spectrometry." The report covers sample preparation, method calibration and repeatability analysis.

The functional properties of lubricating oil for specific purposes are established by mixing additives with base oil.
Controlling the concentrations of additive elements is fundamental in lubricating oil production plants. X-ray fluorescence (XRF) spectrometry is used for quantitative analysis of additive elements such as magnesium (Mg), phosphorus (P) and zinc (Zn) in lubricating oil because of its high precision and simple sample preparation requirements. In the XRF analysis of lubricating oil, a sample is simply poured into a liquid cell. No complicated treatment, such as chemical decomposition or dilution, is required.

As described in the report, the analysis is carried out on the Rigaku ZSX Primus WDXRF spectrometer, a system that is optimized for routine analyses commonly performed by today’s petroleum laboratories. The spectrometer was equipped with a 3 kW Rh-target X-ray tube. A 4 kW X-ray tube can be mounted if higher sensitivity or precision is required. The operation software is designed for ease of use in routine analyses, guiding users through establishing calibrations. The calibration curves were generated with matrix corrections applied for all analytes except for Mg, as indicated in ASTM D6443-04. Repeatability tests were carried out for two diffe
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Global Mobile Health Application Market 2011-2015 : MarketResearchReports.Biz
2. Strengthening fragile forests of carbon nanotubes for new MEMS applications
3. Portable Spectrometer From Ocean Optics Ideal for Field Applications
4. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
5. New Torrent Suite Software Provides Highest Accuracy and 400 Base Pair Kits Deliver Broader Applications for Ion Semiconductor Sequencing
6. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org
7. MarketsandMarkets: World Sensors Market in Healthcare Applications is expected to reach $13.11 billion by 2017
8. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
9. Enox Biopharma, Inc. Grants TTA LTD License To Wound Care Applications
10. Janssen Submits Additional Marketing Applications for ZYTIGA® in the U.S. and European Union
11. State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications

Post Your Comments:

(Date:5/17/2013)... transplant rejection occurs when the transplant recipient,s immune system ... it. It was previously thought that T cells, the ... by molecules known as chemokines in order to migrate ... Journal of Clinical Investigation , Fadi Lakkis and ... demonstrate that chemokine stimulation of T cells is not ...

(Date:5/17/2013)... The new Public-Private Partnership (PPP) in ... association’s recent annual meeting drew praise from community leaders ... who called the action “a huge step forward … ... European innovation.” , The Board of Stakeholders voted to ... PPP at its 29 April meeting in Brussels, which ...

(Date:5/17/2013)... May 17, 2013 Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...

(Date:5/17/2013)... Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy. The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board. In this study, INS001 appeared safe and ...

Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2 SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3 Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2 Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2

[0] Researchers identify signals that direct the immune system to reject a transplanted organ [0] SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions [0] Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis [0] Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy

... Sonia Moralejo Garca at the University of the Basque Country ... and other magnetic devices of wide industrial application. , It ... that are ever smaller and that nanotechnology, although it its ... in our society. Who has not heard of nanotubes, nanoparticles ...

... INCREASE 14.6%. Q4 2007 DILUTED EPS UP 20.8% TO $.64. 2008 ... $2.62 PER SHARE., ST. LOUIS, Feb. 12 , HIGHLIGHTS: ... -- Q4 2007 Sales Set New Quarterly Record: At $532.1 ... high, beating the Q2 2007 record of $507.5 ...

... of Dow AgroSciences Announces Milestone in Wall Street ... ,Dow AgroSciences LLC and Sangamo BioSciences, Inc. (Nasdaq: ... a key research milestone as part of,their joint ... successful application of Sangamo,s zinc finger DNA-binding,protein nuclease ...

A researcher of UPV/EHU has designed nanomagnets for industry Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration

(Date:5/18/2013)... FL (May 18, 2013) Research presented at ... managing digestive health through diet and lifestyle. ... plagued by reduced muscle strength, fatigue and poor ... when patients are in remission. A randomized, double ... that vitamin D supplementation corresponded to significant relief ...

(Date:5/17/2013)... provide the white noise of the South, but the night ... Southern air hangs heavy from the humidity and the sounds ... 140 species of frogs, toads and salamanders, is the center ... and swamps are the auditorium for their symphonic choruses, the ... Initiative, or ARMI, have front-row seats. , Amphibians, ...

(Date:5/17/2013)... proteins in the brain responsible for protecting nerve cells ... increase cell survival. , The discovery, made by researchers ... the EMBO journal with additional comment in ... stroke and other brain diseases. , The research builds ... protein, known as SUMO, responsible for controlling the chemical ...

Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2 Research examines new methods for managing digestive health 3 Front-row seats to climate change 2 Front-row seats to climate change 3 Front-row seats to climate change 4 SUMO wrestling cells reveal new protective mechanism target for stroke 2

[0] Research examines new methods for managing digestive health [0] Front-row seats to climate change [0] SUMO wrestling cells reveal new protective mechanism target for stroke

... A new study, led by Felix Aigner, M.D., ... as potentially responsible for regulating the body's inflammatory ... complications involved with many transplantations is the damage ... following surgery, known as ischemia and reperfusion (IR). ...

... major role in deadly prion diseases by smashing up ... allow fatal brain illnesses to quickly spread, new Brown ... say, because they might reveal a way to control ... drug could be made that inhibits this fragmentation process, ...

... The costs due to complications from preterm birth are ... preterm infants are estimated to be almost $2 billion ... researchers found that giving nitroglycerin to mothers who had ... baby’s health. The results of the study are reported ...

Cached Biology News:Brown team finds crucial protein role in deadly prion spread 2

Protein may hold key to decreasing organ dysfunction rates in heart transplants Brown team finds crucial protein role in deadly prion spread Plastic that degrades in seawater could be boon for cruise industry and others

...

Rat Antibody to Kinase Suppressor Of Ras Recognises the kinase suppressor of Ras (KSR). Immunogen: Recombinant human KSR protein Specificity: human kinase supressor of Ras...

Request Info...

NATIVE RAT OSTEOCALCIN...

Biology Products:

Mouse Granzyme B ELISpot Kit from R&D Systems Rat Anti-Kinase Suppressor Of Ras Monoclonal Antibody, Unconjugated, Clone MINT/1/4 from GeneTex 8 Channel Syringe Dispenser, 20 cc Capacity from Biosearch Technologies Rat OSTEOCALCIN Native from AbD Serotec